Baxter International Inc. $BAX Shares Sold by Park National Corp OH

Park National Corp OH reduced its stake in shares of Baxter International Inc. (NYSE:BAX) by 92.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,840 shares of the medical instruments supplier’s stock after selling 246,802 shares during the quarter. Park National Corp OH’s holdings in Baxter International were worth $360,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of BAX. EverSource Wealth Advisors LLC boosted its holdings in Baxter International by 14.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 5,448 shares of the medical instruments supplier’s stock worth $124,000 after acquiring an additional 686 shares during the period. CoreFirst Bank & Trust purchased a new stake in shares of Baxter International during the second quarter valued at approximately $27,000. Public Employees Retirement System of Ohio raised its stake in shares of Baxter International by 0.6% during the third quarter. Public Employees Retirement System of Ohio now owns 160,033 shares of the medical instruments supplier’s stock valued at $3,644,000 after purchasing an additional 993 shares during the period. Imprint Wealth LLC acquired a new position in shares of Baxter International during the third quarter worth $27,000. Finally, CYBER HORNET ETFs LLC acquired a new position in shares of Baxter International during the second quarter worth $40,000. 90.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently weighed in on BAX. Morgan Stanley lowered their price target on shares of Baxter International from $19.00 to $15.00 and set an “underweight” rating for the company in a report on Tuesday, December 2nd. The Goldman Sachs Group cut their price objective on shares of Baxter International from $21.00 to $17.00 and set a “neutral” rating on the stock in a report on Friday, February 13th. Weiss Ratings reissued a “sell (d)” rating on shares of Baxter International in a research report on Wednesday, January 21st. Jefferies Financial Group lowered their target price on Baxter International from $21.00 to $19.00 and set a “hold” rating for the company in a research note on Friday, February 13th. Finally, Citigroup dropped their target price on Baxter International from $21.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 11th. Two equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $19.90.

Baxter International Stock Down 2.8%

BAX stock opened at $16.20 on Friday. The company has a market capitalization of $8.34 billion, a price-to-earnings ratio of -8.75, a price-to-earnings-growth ratio of 1.17 and a beta of 0.58. The company has a current ratio of 2.31, a quick ratio of 1.56 and a debt-to-equity ratio of 1.55. Baxter International Inc. has a 52 week low of $16.08 and a 52 week high of $34.51. The firm’s 50-day moving average is $19.66 and its two-hundred day moving average is $20.37.

Baxter International (NYSE:BAX) last announced its earnings results on Thursday, February 12th. The medical instruments supplier reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.53 by ($0.09). Baxter International had a negative net margin of 8.51% and a positive return on equity of 16.95%. The firm had revenue of $2.97 billion for the quarter, compared to the consensus estimate of $2.82 billion. During the same period in the prior year, the business earned $0.58 EPS. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.850-2.050 EPS. On average, analysts forecast that Baxter International Inc. will post 2.48 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Friday, February 27th will be issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, February 27th. Baxter International’s payout ratio is presently -2.16%.

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.